ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2839

Microrna Expression in the Vasculitic Skin Lesions of Adult Patients with IgA Vasculitis

Alojzija Hočevar1, Matija Tomšič2, Jože Pižem3, Luka Bolha3, Snezna Sodin Semrl4 and Damjan Glavač3, 1Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 2University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia, 3Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, 4University of Primorska, Faculty of Mathematics, Natural Science and Information Technology, Koper, Slovenia

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: MicroRNA and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T093 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os II: Novel Diagnostics & THRs (2838–2843)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: IgA vasculitis (IgAV) represents a common systemic vasculitis in paediatric and adult population. Our current knowledge of disease pathogenesis is still very limited and information on miRNAs expression in IgAV is lacking. The aim of our study was to determine the expression of five miRNAs (miRNA-146a-5p, miRNA-148-3p, miRNA-155-5p, miRNA-223-3p and let-7b) in the affected skin of adult IgAV patients.

Methods: The study included 65 skin samples from consecutive, untreated IgAV patients (61.5% male, median age 67.6 years, range 29–91), and 20 samples of normal skin from healthy volunteers. Total RNA was isolated from tissue sections of formalin-fixed, paraffin-embedded samples. Expression of miRNAs was measured using qRT-PCR. To present relative miRNA expression, the ΔΔCT method was used. Skin miRNAs expression was correlated to clinical characteristics of adult IgAV patients.

Results: We found significantly higher levels of miRNA-155-5p, miRNA-223-3p and let-7b in the affected skin compared to controls (18.6-fold, 6.4-fold and 7.9-fold higher respectively). Contrary, the mi-RNA 148-3p expression was significantly lower (2.2-fold). The expression of the miRNA-146-5p was near normal levels. Patients with necrotic skin lesions had significantly higher miRNA-223 tissue expression than those with non-necrotic purpura (p=0.029). Gastrointestinal tract involvement inversely correlated with the expression of miRNA-155-5p (p=0.004) and/or miRNA-146a-5p (p=0.041) in affected skin. No significant association between renal involvement or its severity, and skin expression of the investigated miRNAs was found. Patients with elevated serum IgA had a borderline upregulated skin expression of miRNA 223-3p (p=0.053).

Conclusion: An altered expression of miRNA-148b-3p, miRNA-155-5p, miRNA-223-3p and let-7b was found in vasculitic skin lesions in IgAV. The study revealed potential associations between the selected miRNA expression patterns and specific disease manifestations. Aberrantly expressed miRNAs could represent a biomarker in adult IgAV.


Disclosure: A. Hočevar, None; M. Tomšič, None; J. Pižem, None; L. Bolha, None; S. Sodin Semrl, None; D. Glavač, None.

To cite this abstract in AMA style:

Hočevar A, Tomšič M, Pižem J, Bolha L, Sodin Semrl S, Glavač D. Microrna Expression in the Vasculitic Skin Lesions of Adult Patients with IgA Vasculitis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/microrna-expression-in-the-vasculitic-skin-lesions-of-adult-patients-with-iga-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microrna-expression-in-the-vasculitic-skin-lesions-of-adult-patients-with-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology